NCT03125577 - Combination CAR-T Cell Therapy Targeting Hematological Malignancies | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions

B-cell Malignancies

Interventions

BIOLOGICAL

4SCAR19 and 4SCAR22

BIOLOGICAL

4SCAR19 and 4SCAR38

BIOLOGICAL

4SCAR19 and 4SCAR20

BIOLOGICAL

4SCAR19 and 4SCAR123

BIOLOGICAL

4SCAR19 and 4SCAR70

BIOLOGICAL

4SCAR19 and 4SCAR30

Trial Locations (4)

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

RECRUITING

Shenzhen Geno-immune Medical Institute, Shenzhen

RECRUITING

Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, Kunming

All Listed Sponsors

lead

Shenzhen Geno-Immune Medical Institute

OTHER